United States · 
Who invested in ImmunoMet Therapeutics?
ImmunoMet Therapeutics's investors include Mirae Asset Venture Investment and SL Investment.
202120222023202420252026
$7.0MSeries B$842KRoundUnited States · Series B startup
Who invested in ImmunoMet Therapeutics
2 rounds we have observed, with the 2 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Raised 9 months ago
Funding summaryUpdated 26 Oct 2026
$7.8Mraised across 2 rounds since 2021, from 2 sources
$7.0MSeries B$842KRound
- Latest round
- Round, $842KJan 2026
- Biggest round
- $7.0MSeries B · Feb 2021
- Investors
- 2
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Series B, $7.0M Feb 2021
- Biggest round
- $7.0M Series B · Feb 2021
- Between rounds
- 5 years from the last two
The rounds
- Jan 2026Round$842K
No investor was named in the report.
Filed with the SEC (Form D); no report of this raise yetSEC filing: $842K sold, first sale Jan 2026
- Feb 2021
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Everyone who backed them
SL InvestmentPrivate equity1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about ImmunoMet Therapeutics
How much has ImmunoMet Therapeutics raised?
ImmunoMet Therapeutics has raised $7.8M across 2 rounds since 2021.
When did ImmunoMet Therapeutics last raise?
ImmunoMet Therapeutics's most recent round, $842K, was in Jan 2026.
What was ImmunoMet Therapeutics's biggest round?
ImmunoMet Therapeutics's largest round on record is $7.0M (Series B), in Feb 2021.
Who backed ImmunoMet Therapeutics first?
ImmunoMet Therapeutics's first round on record, in Feb 2021, was backed by Mirae Asset Venture Investment and SL Investment.
What stage is ImmunoMet Therapeutics at?
ImmunoMet Therapeutics's latest named round is a Series B, in Feb 2021.
Where is ImmunoMet Therapeutics based?
ImmunoMet Therapeutics is based in the United States.
Companies like ImmunoMet Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.